ENLIVEN THERAPEUTICS INC (ELVN) Stock Balance Sheet
NASDAQ:ELVN - Nasdaq - US29337E1029 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 101.70M | 124.12M | 100.14M | 75.54M | 48.31M | |||
| Marketable Securities | 187.85M | 189.32M | 153.01M | N/A | 41.97M | |||
| Other Current Assets | 4.76M | 4.69M | 13.00M | 2.22M | 2.42M | |||
| Total Current Assets | 294.32M | 318.13M | 266.15M | 77.75M | 92.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.05M | 458.00K | 1.06M | 1.52M | 780.00K | |||
| Other Non-Current Assets | 7.20M | 7.17M | 4.65M | 4.03M | 180.00K | |||
| Total Non-Current Assets | 8.25M | 7.63M | 5.72M | 5.55M | 950.00K | |||
| TOTAL ASSETS | 302.57M | 325.76M | 271.87M | 83.30M | 93.65M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 12.41M | 14.57M | 15.36M | 6.60M | 4.85M | |||
| Accounts Payable | 1.56M | 1.34M | 532.00K | 3.12M | 2.36M | |||
| Other Current Liabilities | N/A | 0.00 | 10.00M | N/A | N/A | |||
| Total Current Liabilities | 13.97M | 15.91M | 25.89M | 9.72M | 7.21M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 302.00K | 0.00 | 67.00K | 660.00K | 410.00K | |||
| Total Non-Current Liabilities | 302.00K | 0.00 | 67.00K | 650.00K | 410.00K | |||
| TOTAL LIABILITIES | 14.27M | 15.91M | 25.96M | 10.37M | 7.62M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -272.02M | -243.47M | -154.45M | -82.86M | -147.50M | |||
| Additional Paid In Capital | 560.28M | 553.21M | 400.17M | 6.04M | 233.52M | |||
| Common Shares | 49.00K | 49.00K | 41.00K | 149.75M | 30.00K | |||
| Other Shareholders' Equity | -16.00K | 55.00K | 141.00K | N/A | -20.00K | |||
| Shares Outstanding | 49.04M | 48.94M | 41.35M | 3.57M | 6.57M | |||
| Tangible Book Value per Share | 5.88 | 6.33 | 5.95 | -21.52 | 13.09 | |||
| Total Shareholders' Equity | 288.30M | 309.85M | 245.91M | 72.92M | 86.03M | |||
| TOTAL LIABILITIES AND EQUITY | 302.57M | 325.76M | 271.87M | 83.30M | 93.65M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 21.06 | 19.99 | 10.28 | 8.00 | 12.86 | |||
| Return On Assets (ROA) | -31.34% | -27.33% | -26.33% | 1.79% | -54.86% | |||
| Return On Equity (ROE) | -32.89% | -28.73% | -29.11% | 2.04% | -59.72% | |||
All data in USD , ROIC based on taxRate of 0.21